| 1Related Compound B |
|---|
| 2Related Compound D |
| 3Related Compound G |
| 4Rivaroxaban |
| 5Related Compound J |
search
Applications
USP Rivaroxaban Assay and Organic Impurities - System Suitability Solution run on AgilentĀ® 1260
28024
Separation Mode: Reversed Phase
Reversed Phase
C18
HPLC
Pharmaceutical
Pharmaceutical
Therapeutic / Clinical
USP Rivaroxaban Assay and Organic Impurities - System Suitability Solution run on AgilentĀ® 1260
Analytes
Details
LC Conditions (App ID: 28024)
Column: |
Brand Name: Luna Omega |
Part No: |
Phase Name: C18 |
System: Agilent Technologies 1200 Series Agilent Technologies 1200 Series |
Sample Note: Solution B: 5.3mM sodium hexane sulfonate, 3.77mM phosphoric acid in water
Diluent: Acetonitrile and solution B (40:60)
System suitability solution: 0.5 mg/mL of USP Rivaroxaban RS and 0.5 Āµg/mL each of USP Rivaroxaban Related Compound B RS, USP Rivaroxaban Related Compound D RS, USP Rivaroxaban Related Compound G RS, and USP Rivaroxaban Related Compound J RS in Diluentā
peak no. 1
analyte name: rivaroxaban related compound G
RT (min): 14.099
conc.: 0.5ug/mL
peak no. 2
analyte name: rivaroxaban
RT (min): 15.66
conc.: 0.5mg/mL |
Similar Applications
search
No Data
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide